SIRT1 and hepatocellular carcinoma: In fact, in a study conducted by Portmann et al. [27], small molecule SIRT1 inhibitor—cambinol treatment of human hepatocellular carcinoma (HCC) cell lines showed that this agent had a cytostatic effect, including the alteration of cell morphology and cellular senescence.